Lv5
840 积分 2025-12-16 加入
Activation of Nerve Growth Factor signaling limits the response to lenvatinib in hepatocellular carcinoma
1天前
待确认
Impact of LEAP-012 and EMERALD-1 in the management of HCC
14天前
已关闭
DysUFMylation reprograms immunosuppressive neutrophils to potentiate anti-PD-1 therapy in hepatocellular carcinoma
14天前
已完结
EGFR activation limits the response of liver cancer to lenvatinib
27天前
已完结
Five tenets for advancing evidence-based precision medicine
27天前
已完结
Laminin β1 stimulates the Hippo-YAP1 pathway to advance the progression and lenvatinib resistance in hepatocellular carcinoma
30天前
已完结
Burden of liver cancer and underlying etiologies in China from 1990 to 2021: A systematic analysis from the Global Burden of Disease Study 2021
1个月前
已完结
Multicenter single-arm phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab
1个月前
已关闭
MRI-based Risk Scoring System to Predict Early Recurrence after Resection of Solitary Hepatocellular Carcinoma 5 cm or Smaller
1个月前
已完结
Impact of Procedural Quality on Outcomes of Transarterial Chemoembolization for Hepatocellular Carcinoma: A Multicenter Study
1个月前
已完结
皖公网安备34019202002308
